As a spontaneous replicating source of normal cells or DNA from a single individual, Lymphoblastoid cell lines (LCLs) have been widely used and substantially accelerated the process of biological investigations. In human genetics and genomics, LCLs provide a constant supply of DNA material for variety of assays and studies. For example, LCLs were applied as tools in vitro for evaluating drug targets and pathways[@b1], also in vitro cell model for pharmacogenomic studies exploring genetic variation by drug dosage or cytotoxicity[@b2]. Besides, LCLs have provided unlimited genetic materials for human genetic studies[@b3] and for human population genetic studies to characterize genetic variation of different individuals from multiple populations[@b4][@b5][@b6]. Especially, LCL derived DNA from the Coriell Cell Repositories (<http://ccr.coriell.org/>) were used for whole-genome genotyping and sequencing in the International HapMap Project and the 1000 Genome Project, the two largest international collaborative efforts in human genomics field since the Human Genome Project. Apart from genomics studies, LCL derived RNA was also used recently for gene expression studies. For example, Epstein--Barr virus-immortalized lymphoblastoid cell lines from the CEPH/CEU (Centre d\'Etude du Polymorphisme Humain -- Utah) family resource have been used for examining the genetics of gene expression levels[@b5][@b7]. Especially, several recent papers reported differential gene expression between CEU and YRI (Yoruba in Ibadan, Nigeria)[@b8][@b9][@b10].

However, CEU/CEPH cell lines were collected and transformed much earlier than the other cell lines from the pertaining individuals[@b11][@b12], which we suspected could potentially affect gene expression. Indeed, some previous studies reported that the older age of CEU cell lines compared to those more recently established cell lines could bias gene expression heterogeneity between populations[@b9]. In this study, taking advantage of the availability of RNA sequencing (RNA-Seq) data which allow for relatively unbiased measurements of expression levels across the entire length of transcripts[@b7], we systematically examined and evaluated the potential confounding effect of LCL age on gene expression levels and patterns. This dataset is ideal to address the question we asked in this study. On the one hand, RNA-Seq data of three European populations (GBR, TSI and FIN), which are genetically close to CEU but the LCLs of these three population samples were established very recently, can be used as very good controls to examine whether and to what extent the gene expression profile of CEU deviated from normal level. On the other hand, analysis can be done for verification of the results reported by previous studies based on microarray data. Especially the differential gene expression between CEU and YRI identified by previous studies can be re-examined in the new RNA-Seq data (see Materials and Methods).

Results
=======

We analyzed both RNA-Seq data and DNA sequence data obtained from an identical set of samples (462 individuals, [Table 1](#t1){ref-type="table"}) representing the four European populations (EUR), i.e. Utah residents with Northern and Western European ancestry from the CEPH collection (CEU, n = 91), Tuscans from Italy (TSI, n = 93), Finnish in Finland (FIN, n = 95) and British in England and Scotland (GBR, n = 94), and one African population, i.e. Yoruba in Ibadan, Nigeria (YRI, n = 89). When we compared gene expression level between populations, we found that CEU-YRI pair showed larger differences (measured by V~ST~ based on RNA-Seq data) than those non-CEU-YRI pairs. Similarly, CEU-EUR pairs showed larger V~ST~ compared to other EUR pairs while genetic difference (measured by F~ST~ based on DNA variation data) between any European population pairs was very small. These results indicated CEU could have a different expression profile compared with the other European populations. In addition, we observed a strong positive correlation between expression differentiation (V~ST~) and genetic differentiation (F~ST~) ([Figure 1A](#f1){ref-type="fig"}, r^2^ = 0.8, *p* \< 0.01). This correlation between expression differentiation and genetic differentiation was even much stronger when CEU samples were excluded from the analysis (r^2^ = 0.98, *p* \< 0.01, [Figure 1B](#f1){ref-type="fig"}). Correspondingly, we did observe that population pairs with CEU involved showed apparent deviation from the correlation relationship ([Figure 1A](#f1){ref-type="fig"}). Therefore, it seemed that the gene expression profile of CEU could be different from those of the other European populations, despite the overall transcriptomic profile of CEU is unexpected to be significantly different from those of the other European populations given the small genetic difference among European populations (mean F~ST~ = 0.005, [Figure 1A](#f1){ref-type="fig"}). Indeed, our further analysis did reveal a significant deviation of gene expression profile of CEU from those of the other three European populations (TSI, FIN and GBR) ([Figure 1C](#f1){ref-type="fig"}, t test *p* \< 2.2e-16).

The above results suggested that some special factors contributed to the unique expression profile of CEU because the gene expression difference could not be explained by the small genetic difference between CEU and the other European populations (mean F~ST~ = 0.005). Spirited by this understanding and sense, we identified 2,420 genes showing significant expression differentiation between CEU and the other three European populations but no significant expression differentiation among the non-CEU European populations (TSI/FIN/GBR) ([Figure 1D](#f1){ref-type="fig"}). We further performed functional annotation and enrichment analysis of these 2,420 differentially expressed (DE) genes between CEU and the other European populations ([Figure 1D](#f1){ref-type="fig"}), taking all the 14,178 expressed genes as a background control. Notably, we identified a series of cell specific GO (Gene Ontology) functions including endomembrane system, Golgi vesicle transport, intracellular organelle part, cell, cytoplasmic part and cellular response to topologically incorrect protein, etc. (Bonferroni-corrected *p* \< 0.01, see Materials and Methods, [Table 2](#t2){ref-type="table"}). Since these DE genes are enriched to functions related to cell secretion and cell proliferation, which played an important role in cell subculture, it is intuitive and reasonable to attribute CEU-specific gene expressions to the relative older age of CEU cell lines.

Further, we performed a comparative analysis of RNA sequencing data between African (YRI) and European populations. In this way, YRI was used as an outgroup to reduce the potential background noise in comparing gene expression data in closely related populations. Interestingly, the DE genes between CEU and YRI were over-represented in the 2,420 genes showing CEU-specific gene expressions compared with DE genes between non-CEU European (TSI/FIN/GBR) and YRI (one side Fisher exact test *p* = 0, [Figure 2](#f2){ref-type="fig"}). These results again indicated that a substantial proportion of DE genes between CEU and YRI (around 24%, [Figure 2](#f2){ref-type="fig"}) were unlikely due to genetic difference between the two populations, but were instead likely to be resulted from old age of cell lines. Finally, we compared the DE genes identified between CEU and YRI based on RNA-Seq data with the previously reported DE genes between CEU and YRI based on microarray platform[@b8]. As a result, we found that 31 DE genes reported by previous studies, as representative signatures of differential gene expression between African and European populations, could be false positive results due to older age of CEU cell lines, i.e. *TRIP4, PITPNB, TAOK3, SAMD8, GOLGA7, PTPN12, ACOT9, FTSJ3, C19orf12, UTP14A, CLEC2D, RNF170, ALG11, UTP14C, HOOK3, YES1, PPP3CC, SERPINB9, PPHLN1, SYNCRIP, TM9SF3,GBP1, SFMBT1, FMR1, PAPLN, SNTB1, OXER1, TNFRSF13B, FAM91A1, KIAA1033, SLC39A8*. Therefore, we suggested caution be paid to these genes on expression analysis involving LCLs from the CEPH/CEU family resource in future work.

Discussion
==========

This study was initially motivated by an observation in our data analysis of apparent deviation of gene expression profile of CEU samples from those of the other populations including several European populations which are genetically very closely related to CEU. Lymphoblastoid cell lines (LCLs) are a resource that provides investigators with the nearly unique opportunity to perform in-depth studies of molecular and complex phenotypes using the same collection of samples. However, results based on LCLs in human genetics can be sometimes controversial. The transformation that immortalized the LCLs, through the infection of primary B cells with EBV, was known to result in certain artifacts[@b13]. Cell lines that often carry chromosomal abnormalities[@b14] might have pronounced batch effects related to preparation and/or growth rates[@b13], and the Epstein--Barr virus (EBV) transformation itself could alter the methylation status[@b15] and expression levels of a subset of genes[@b16][@b17]. Most importantly, during the long-term subculture, genotypic errors were incorporated mostly in late-passage, but not in early-passage LCLs[@b18]. We noted that CEU/CEPH cell lines were collected and transformed approximately thirty years ago, much earlier than the other cell lines from the pertaining individuals, which we suspected could potentially affect gene expression. Indeed, it has been reported that the greater number of the validated non-germline mutations in the CEU cell line perhaps reflected the greater age of the CEU cell culture[@b4]. Since gene expression could be treated as an important heritable trait[@b5][@b19][@b20], it was expected to detect a profound difference in the gene expression profiles between newly established and mature LCLs[@b21], also the older age of CEU cell lines compared to those more recently established cell lines could bias gene expression heterogeneity between populations[@b13][@b22]. Although this unwanted bias caused by the age of the cell lines has been noted before in the literature, few studies have systematically evaluated the influence of this effect on gene expression patterns. To this end, we took advantage of recently available RNA-Seq data and methods that allowed us to address this question. We found apparent deviation of gene expression profile of CEU samples from those of the other populations including several European populations which were genetically very closely related to CEU. Therefore, it was reasonable to infer that gene expression level and pattern of CEU cell lines have been biased by the older age of CEU cell lines, which would spark concern about CEPH cell lines. However, the CEU-specific expression could also be the result of environment effects or gene by environment interactions, as suggested previously[@b23]. So, our analysis did not rule out the possibility that other factors might also affect gene expression levels. We emphasize here, however, that our current study is not a comprehensive one to access the relationship between cell line age and gene expression, but rather provide some warning messages for interpretation of the results of previous studies based on CEU cell lines and useful information for future study design.

In addition, we identified 2,420 genes whose expression levels are highly differentiated between CEU and the other European populations and probably associated with old age of CEU cell lines. Notably, these 2,420 genes showing CEU-specific expression were enriched in the 3,259 genes reported as eQTL in European populations (CEU/GBR/TSI/FIN) in the previous study[@b7] (one side fisher exact test *p* = 0.047), compared to 501 eQTL genes in YRI population. These results could be best explained by some special characters in CEU cell lines which were very likely due to the earlier established time of CEU cell lines. Since there is no easy way to correct the biased gene expression in CEU empirically or statistically, what we could do is avoiding the possible false-positive results by referring genes as we have already listed in this paper, and do not over-interpret the differential gene expression if they are found in the comparisons between CEU and other populations. In brief, we suggested these CEU-specific gene expression be explained with caution, and this issue of cell line age be carefully considered in the analysis of CEU gene expression data, especially when CEU LCLs were used for transcriptomic data analysis in future studies.

Methods
=======

RNA-Seq data and gene expression quantification
-----------------------------------------------

We downloaded an RNA-Sequencing dataset from ArrayExpress, which spanned the whole genome expression data in transformed lymphoblastoid cell lines (LCLs) obtained from 5 populations (in total 462 samples, [Table 1](#t1){ref-type="table"}) with different ancestries: Utah residents with Northern and Western European ancestry (CEU, 91 samples), British in England and Scotland (GBR, 94 samples), Tuscans in Italy (TSI, 93 samples), Finnish in Finland (FIN, 95 samples) and Yoruba in Ibadan, Nigeria (YRI, 89 samples), respectively[@b7]. The sample sizes for two sexes are nearly equal ([Table 1](#t1){ref-type="table"}). Reads mapping and quality control were fulfilled by the original study[@b7], which resulted in 57,195 Ensembl genes in total. Then, we quantified reads for the whole transcripts and each quantification was filtered to exclude those with missing data for \>10% of the individuals in all of the five populations. This resulted in 14,178 Ensembl genes and 111,120 transcripts on 22 autosomes and X chromosome. The transcript read counts were subsequently normalized by per kilobase per million reads (RPKM) measure.

Replication of gene expression differences between CEU and YRI on a microarray platform
---------------------------------------------------------------------------------------

We checked whether the RNA-Seq dataset could replicate gene expression differences between CEU and YRI in a previous study[@b8], the gene expression data of which were generated with the Affymetrix GeneChip Human Exon 1.0 ST array and it reported 383 differential transcript clusters between the CEU and YRI samples, of which 306 were located in protein coding region. We could replicate 266 (87%) of them based on Benjamini-Hochberg corrected t test (*p* \< 0.05).

Genotype data and estimation of genetic differentiation between populations
---------------------------------------------------------------------------

Single nucleotide polymorphisms (SNPs) data of the same 462 samples was obtained from the 1000 Genomes Project Phase I dataset[@b24]. In each population, only the polymorphic SNPs on 22 autosomes and X chromosome were included. For each SNP, genetic difference between populations was measured with the commonly used F~ST~ according to Wright\'s approximate formula[@b25]. F~ST~ value was calculated based on allele frequencies estimated from unrelated individuals in each population.

Quantification of expression difference between populations
-----------------------------------------------------------

To quantify population differentiation with respect to expression levels, we calculated V~ST~ for each of the transcript between any two of the four populations. V~ST~ is a measure of the proportion of variance on expression level explained by between-population differences, and is analogous to the commonly used population genetics parameter F~ST~, which measures allele frequency differences between populations. For a single transcript compared between two populations, V~ST~ is calculated as: (V~T~ -- V~S~)/V~T~, where V~T~ is the total variance across all individuals of the pair of populations and V~S~ is the average within-population variance weighted by each population sample size. V~S~ = (V~1~\*n~1~ + V~2~\*n~2~)/(n~1~ + n~2~), where V~1~ is the within-population variance of population 1, V~2~ is the within population variance of population 2, and n~1~ and n~2~ are the numbers of individuals sampled from population 1 and 2, respectively. V~ST~ values range from 0 to 1, with values near 1 signifying that the majority of gene expression variance for a transcript segregates between populations rather than within populations.

Statistical test for differential expression between populations
----------------------------------------------------------------

For each transcript, we applied Shapiro-Wilk test of expression levels\' normality, with the cutoff of Bonferroni-corrected *p* \< 0.01. We found the majority of transcripts followed normal distribution in gene expression levels for all the 5 populations (92%, 96%, 95%, 94% and 94% transcripts for CEU, GBR, FIN, TSI and YRI, respectively). Therefore, T-test was applied to test whether the transcript expressions were significantly different between any two populations, with the cutoff of Bonferroni-corrected *p* \< 0.01.

Functional annotation and enrichment analysis of differential expression
------------------------------------------------------------------------

Due to the unique properties of the RNA-Seq data, the differential expression of longer transcripts is more likely to be identified than that of shorter transcripts with the same effect size[@b26]. This transcript length bias complicates the downstream GO analysis[@b27]. To correct this confounding effect, we applied "GOseq"[@b27] to perform functional annotation and enrichment analysis of these 2,420 differentially expressed (DE) genes between CEU and the other European populations ([Figure 1D](#f1){ref-type="fig"}), using all the 14,178 expressed genes as a comparison background.
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![(A) Distribution of genetic differentiation (F~ST~) and expression differentiation (V~ST~) between each pair of the five populations (CEU/TSI/FIN/GBR/YRI). The asterisks represent population pairs CEU involved and the triangles represent non-CEU involved pairs. The four red markers on the upper panel show the population pairs between YRI and European populations, the blue markers on the bottom right panel show the population pairs between CEU and non-CEU European populations, and the gray markers on the bottom left panel show the population pairs between non-CEU European populations. The gray dashed line represents the regression line between F~ST~ and V~ST~ for the 10 population pairs. The correlation between the mean V~ST~ values and mean F~ST~ values is shown above the plot. (B) Distribution of genetic differentiation (F~ST~) and expression differentiation (V~ST~) between each pair of the four non-CEU populations (TSI/FIN/GBR/YRI). The three red markers on the upper panel show the population pairs between YRI and European populations and the three gray markers on the bottom panel show the population pairs between non-CEU European populations. The gray dashed line represents the regression line between F~ST~ and V~ST~ for the 6 population pairs. The correlation between the mean V~ST~ values and mean F~ST~ values is shown above the plot. (C) Distribution of V~ST~ between each pair of European populations. The red solid, dashed and dotted lines represent population pairs between CEU and three other non-CEU Europeans (TSI/FIN/GBR). The blue solid, dashed and dotted lines represent population pairs between three non-CEU Europeans (TSI/FIN/GBR). (D) Venn diagram of DE genes. The yellow circle represents the number of DE genes between CEU and other non-CEU European populations (TSI/FIN/GBR) and the purple circle represents the number of DE genes between any two non-CEU European populations (TSI/FIN/GBR).](srep07960-f1){#f1}

![Venn diagram of DE genes.\
The big and red circles represent the number of DE genes between CEU and YRI. The green circles represent the 2420 genes described in [Figure 1D](#f1){ref-type="fig"}. The blue circles represent the number of DE genes between YRI and the other non-CEU European populations: TSI, FIN and GBR respectively in (A)--(C).](srep07960-f2){#f2}

###### Information of population samples with both genotyping data and RNA-Seq data available

  Population    Sample size   Sex ratio (F:M)
  ------------ ------------- -----------------
  CEU               91             46:45
  GBR               94             49:45
  FIN               95             58:37
  TSI               93             44:49
  YRI               89             49:40

###### Functional annotation and enrichment analysis of 2,420 genes with differential expression between populations

  Gene Ontology category                                           \#DE Genes[a](#t2-fn1){ref-type="fn"}   \#Other genes[b](#t2-fn2){ref-type="fn"}   *P-value for enrichment*[c](#t2-fn3){ref-type="fn"}
  --------------------------------------------------------------- --------------------------------------- ------------------------------------------ -----------------------------------------------------
  endoplasmic reticulum                                                             263                                      1025                                        1.68 × 10^−9^
  endoplasmic reticulum part                                                        199                                      741                                         2.82 × 10^−8^
  endomembrane system                                                               350                                      1471                                        5.12 × 10^−8^
  endoplasmic reticulum membrane                                                    174                                      637                                         1.38 × 10^−7^
  Nuclear outer membrane-endoplasmic reticulum membrane network                     174                                      649                                         6.75 × 10^−7^
  Golgi membrane                                                                    131                                      460                                         1.63 × 10^−5^
  organelle membrane                                                                434                                      2016                                        2.38 × 10^−5^
  membrane-bounded organelle                                                       1487                                      8001                                        1.43 × 10^−4^
  cellular_component                                                               2145                                     12036                                        1.91 × 10^−4^
  intracellular membrane-bounded organelle                                         1482                                      7979                                        1.92 × 10^−4^
  cytoplasm                                                                        1396                                      7495                                        3.15 × 10^−4^
  Golgi vesicle transport                                                           59                                       169                                         4.13 × 10^−4^
  Golgi apparatus part                                                              140                                      527                                         4.88 × 10^−4^
  organelle                                                                        1590                                      8652                                        7.98 × 10^−4^
  Golgi apparatus                                                                   223                                      936                                         1.09 × 10^−3^
  cell                                                                             1962                                     10891                                        1.10 × 10^−3^
  cell part                                                                        1962                                     10891                                        1.10 × 10^−3^
  intracellular organelle part                                                     1008                                      5289                                        1.11 × 10^−3^
  intracellular organelle                                                          1584                                      8631                                        1.41 × 10^−3^
  cytoplasmic part                                                                 1045                                      5531                                        1.65 × 10^−3^
  intracellular                                                                    1819                                     10034                                        1.73 × 10^−3^
  organelle part                                                                   1015                                      5355                                        3.15 × 10^−3^
  intracellular part                                                               1787                                      9864                                        3.77 × 10^−3^
  cellular response to topologically incorrect protein                              36                                        91                                         6.13 × 10^−3^
  ER-nucleus signaling pathway                                                      38                                        98                                         7.31 × 10^−3^

^a^DE Genes: Number of genes with differential expression between populations in each GO category.

^b^Number of all other background genes within the relevant GO category.

^c^Bonferroni corrected *p*-value.
